Close Menu
    Subscribe
    Uncategorized

    Trinity Biotech shares soar on improved revenue outlook for HIV test

    By No Comments1 Min Read

    Shares of Trinity Biotech rallied after the company boosted the revenue outlook for its rapid HIV test.

    Oh hi there 👋
    It’s nice to meet you.

    Sign up to receive awesome content in your inbox, every month.

    We don’t spam! Read our privacy policy for more info.

    Share.

    Related Posts

    Add A Comment
    Leave A Reply